Samuel Okwuada

Samuel (Kessington) Okwuada is an accomplished professional with a diverse leadership background, currently serving as the Chief Executive Officer of Remedial Health, a company that participated in Y Combinator's Winter 2022 cohort. Samuel holds director roles at both Kessintech and Macbundler, and previously worked as a pre-registration pharmacist at Bell Chemist. Furthering education through Harvard Business School Executive Education, Samuel is set to enhance business skills from May to August 2024, and gained valuable experience at Y Combinator earlier in 2022. Samuel is actively involved in professional organizations as a member of YPO.